HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11

Rhea-AI Summary

HTG Molecular Diagnostics (Nasdaq: HTGM) will announce its financial results for Q2 2022 on August 11, 2022, following market close. A conference call is scheduled for 4:30 PM ET to discuss these results and present a corporate update. The call can be accessed via toll-free and international lines, and listeners can join the webcast through the provided link. HTG is focused on advancing precision medicine using its transcriptome-wide profiling technology, emphasizing its commitment to effective diagnostics and drug discovery.

Positive

• HTG's innovative transcriptome-wide profiling technology positions it strongly within the precision medicine sector.
• The scheduled conference call reflects transparency and engagement with investors regarding financial performance.

Negative

• None.

TUCSON, Ariz., Aug. 04, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the quarter ended June 30, 2022 after the market close on Thursday, August 11, 2022.

Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Details for the conference call are as follows:

Conference Call & Webcast Details
Date:	Thursday, August 11
Time:	4:30pm ET
Toll Free:	1-800-954-0602
International:	1-212-231-2936
Conference ID:	22019810
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1560944&tp_key=20e2ece390

About HTG:

HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, novel therapeutics and clinical diagnostics across a variety of disease areas.

Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG’s proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery. For more information visit www.htgmolecular.com.

HTG Investor Contact:
 
Ashley Robinson
LifeSci Advisors
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com

FAQ

When will HTG report its Q2 2022 earnings?

HTG will report its Q2 2022 earnings after market close on August 11, 2022.

What time is the HTG conference call for Q2 2022 results?

The HTG conference call for Q2 2022 results is scheduled for 4:30 PM ET on August 11, 2022.

How can I access the HTG conference call?

The HTG conference call can be accessed via toll-free number 1-800-954-0602 or international number 1-212-231-2936, using Conference ID 22019810.

What is HTG's focus in precision medicine?

HTG is focused on advancing precision medicine through its transcriptome-wide profiling technology for diagnostics and drug discovery.